Related Experiment Video

Updated: May 8, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
08:26

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

[Evolving strategies over time for treatment of breast cancer]

Henri Roché1

  • 1Institut Claudius-Regaud, département d'oncologie médicale, 20-24, rue du Pont-Saint-Pierre, 31052 Toulouse cedex, France.

Bulletin Du Cancer
|September 6, 2013
PubMed

Insights

The evolution of breast cancer necessitates updated research methods. New approaches are vital to evaluate novel targeted therapies and improve patient outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Phenotypic analysis

Context:

  • Breast disease natural history is evolving.
  • Biological insights into tumor cells are advancing treatment development.
  • Targeted therapies for breast cancer subtypes are emerging.

Purpose:

  • To highlight the need for updated clinical research tools.
  • To address the gap between biological discoveries and current validation methods.
  • To emphasize the requirement for new methodologies in breast cancer research.

Summary:

  • Recent biological discoveries offer new avenues for targeted breast cancer treatments.
  • Traditional research tools lag behind advancements in understanding tumor biology and targeted agents.
  • There is an urgent need for innovative methodologies to validate these advancements and improve prognosis.

Impact:

  • Facilitates the development of more effective, subtype-specific breast cancer treatments.
  • Accelerates the validation of novel therapeutic strategies.
  • Aims to improve long-term patient outcomes and prognosis in breast cancer care.
Keywords:
adjuvant chemotherapyadjuvant hormonotherapybreast cancerradiotherapysurgerytrastuzumab

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...